The Role of Inhibitors of the Epidermal Growth Factor in Management of Head and Neck Cancer

Author： Brockstein Bruce   Lacouture Mario   Agulnik Mark  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.7, 2008-08, pp. : 696-706

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 666-673

Bentham Science Publishers

Access to resources Recommend Favorite

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

By  

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

By Egloff Ann Marie   Grandis Jennifer  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Poly-L-arginine and Dextran Sulfate-Based Nanocomplex for Epidermal Growth Factor Receptor (EGFR) siRNA Delivery: Its Application for Head and Neck Cancer Treatment

By Cho Hyun-Jong   Chong Saeho   Chung Suk-Jae   Shim Chang-Koo   Kim Dae-Duk  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1007-1019

Springer Publishing Company

Access to resources Recommend Favorite